The goal of the funding
The overarching goal is to improve disease prevention and disease management. This should be accomplished based on broader and more efficiently characterized patient stratification, diagnostics, and tailored treatment/prevention protocols.
Research projects in every disease entity are encouraged.
Research proposals submitted under this call are expected to demonstrate the applicability of project outcomes to clinical practice and to combine clinical research with data technologies.
Eligibility
The call is open for researchers with both university or hospital affiliation.
Each consortium submitting a proposal must involve at least three partners. The maximum number of partners per proposal is six, but not more than 2 partners from the same country will be accepted in one project consortium.
Refer to the call for a list of participating countries that are eligible for funding.
Funding
RCN is the funding body for Norwegian participants. In previous calls, RCN has supported 2-3 projects with 800.000 Euros over three years per project.
How to apply and additional information
Applications are submitted through the ERA PerMed application portal. Links to the pre-announcement are listed below.
Timeline
The call is planned to be launched on December 14th 2020 with a submission deadline for pre-proposals on March 4th 2021. It is expected that invited consortia for the full-proposal stage will need to submit their proposal on June 16th, 2021.
Era PerMed pre-announcement
RCN pre-announcement